These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9838560)
1. A two-year study of the new cyclosporine formulation Consupren in de novo renal transplant patients. Stephan AG; Barbari A; Masri M; Kamel G; Barakat Khoury W; Karam A; Mokhbat J; Kilany H Transplant Proc; 1998 Nov; 30(7):3563-4. PubMed ID: 9838560 [No Abstract] [Full Text] [Related]
2. Acute allograft rejection following conversion to a new cyclosporine formulation in pediatric renal transplant patients. Crocker J; Renton K; Wade A; McLellan H; Acott P Transplant Proc; 1998 Aug; 30(5):2002-5. PubMed ID: 9723369 [No Abstract] [Full Text] [Related]
3. High performance liquid chromatography cyclosporine monitoring: a predictor of renal graft outcome. Cicciarelli J; Avila D; Iwaki Y; Sather H; Mendez R Transplant Proc; 1998 Aug; 30(5):1683-4. PubMed ID: 9723243 [No Abstract] [Full Text] [Related]
4. Evaluation of the new cyclosporine formulation, Consupren, in renal transplant patients. Stephan AG; Barbari A; Masri MA; Rizk S; Moubarak R; Frem GJ; Kamel G; Baracat-Khoury W; Karam A Transplant Proc; 1996 Jun; 28(3):1348-9. PubMed ID: 8658688 [No Abstract] [Full Text] [Related]
5. Measurement of lymphocyte cyclosporine levels in transplant patients. Masri MA; Barbari A; Stephan A; Rizk S; Kilany H; Kamel G Transplant Proc; 1998 Nov; 30(7):3561-2. PubMed ID: 9838559 [No Abstract] [Full Text] [Related]
6. A one-year comparative study of Neoral vs Consupren in de novo renal transplant patients. Stephan A; Masri MA; Barbari A; Aoun S; Rizk S; Kamel G Transplant Proc; 1998 Nov; 30(7):3533-4. PubMed ID: 9838547 [No Abstract] [Full Text] [Related]
7. Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice. Vathsala A; Lu YM Transplant Proc; 2001; 33(7-8):3137-9. PubMed ID: 11750348 [No Abstract] [Full Text] [Related]
8. Cyclosporine pharmacokinetics in stable renal transplant patients: effect of formulation Sandimmun versus Consupren versus Neoral. Masri MA; Barbari A; Stephan A; Kamel G; Frem G; Younan F; Rizk S; Moubarak R; Karam A Transplant Proc; 1996 Jun; 28(3):1318-20. PubMed ID: 8658676 [No Abstract] [Full Text] [Related]
9. Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group. Korn A; Färber L; Maibücher A; Buchholz B; Offermann G Transplant Proc; 1997 Nov; 29(7):2945-7. PubMed ID: 9365623 [No Abstract] [Full Text] [Related]
11. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method. First MR; Weiskittel P; Burton M; Shah M; Dreyer D; Fleck P; Bey C; Peddi R; Canafax D; Schroeder TJ Transplant Proc; 1998 Aug; 30(5):1701-5. PubMed ID: 9723249 [No Abstract] [Full Text] [Related]
13. Cyclosporine lymphocyte level and lymphocyte count: new guidelines for tailoring immunosuppressive therapy. Barbari A; Stephan A; Masri M; Mourad N; Kamel G; Kilani H; Karam A; Daya IA Transplant Proc; 2003 Nov; 35(7):2742-4. PubMed ID: 14612101 [No Abstract] [Full Text] [Related]
14. Safety and effectiveness of microemulsion cyclosporine in renal allograft recipients: 1-year follow-up study. Park K; Kim MS; Kim SI; Kim YS; Moon JI Transplant Proc; 1998 Nov; 30(7):3556-7. PubMed ID: 9838557 [No Abstract] [Full Text] [Related]
15. Low exposure to cyclosporine is a risk factor for the occurrence of chronic rejection after kidney transplantation. Citterio F; Torricelli P; Serino F; Foco M; Pozzetto U; Fioravanti P; Castagneto M Transplant Proc; 1998 Aug; 30(5):1688-90. PubMed ID: 9723245 [No Abstract] [Full Text] [Related]